India expects almost ?17,000 crore for the pharmaceutical research and development (R&D) in the period up to FY28, focusing on...
Zydus Lifesciences Limited, a global innovation-driven life sciences company, began exclusive negotiations to acquire an 85.6 percent stake in Amplitude Surgical, whereby the deal is proposed by...
Capitalizing on demographic factors, technological advancements, and increasing demand for quality and preventive care, the healthcare sector of...
Syngene International acquired its first biologics manufacturing site in the United States at $36.5 million, a major expansion in the...
The Department of Pharmaceuticals has invited expression of interest from entities for the purpose of project funding under the Promotion...
A number of Indian pharmaceutical companies are getting ready to release much more affordable generic versions of the diabetes medication empagliflozin. The action comes after Boehringer Ingelheim's patent expired, according to the sources.
Zydus Lifesciences Limited has acquired final permission from the US Food and Drug Administration (USFDA) to manufacture 2% ketoconazole shampoo. According to the company's release today.
Glenmark Pharmaceuticals have a presence in more than 80 countries, and the US market will see the introduction of Polyethylene Glycol 3350 Powder for Solution as an over-the-counter product...
Union Minister Jitendra Singh announced the establishment of BioE3 Cells in states to function as interconnected knowledge centers that will nurture the biomanufacturing sector of India. BioE3 Cells positioned between state and national stakeholders
The Medical Innovations Patent Mitra has been launched by The Indian Council of Medical Research (ICMR) to enhance India’s healthcare innovation and patent ecosystem. Ensuring that biomedical research transla...
, CDSCO.jpg)
